Source: Cellular oncology (Dordrecht, Netherlands) [Cell Oncol (Dordr)] 2024 Apr; Vol. 47 (2), pp. 695-710. Date of Electronic Publication: 2023 Nov 09.Publisher: Springer Country of Publication: Netherlands NLM ID: 101552938 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Analysis of RNA Interference Targeted Against Human Antigen R (HuR) to Reduce Vascular Endothelial Growth Factor (VEGF) Protein Expression in Human Retinal Pigment Epithelial Cells.

Authors : Supe S; Shobhaben Pratapbhai Patel School of Pharmacy and Technology Management, SVKM'S NMIMS, Vile Parle (W), Mumbai, Maharashtra, 400056, India.; Dighe V

Subjects: Vascular Endothelial Growth Factor A*/Vascular Endothelial Growth Factor A*/Vascular Endothelial Growth Factor A*/genetics ; Vascular Endothelial Growth Factor A*/Vascular Endothelial Growth Factor A*/Vascular Endothelial Growth Factor A*/metabolism ; Retinal Pigment Epithelium*/Retinal Pigment Epithelium*/Retinal Pigment Epithelium*/metabolism

Source: Molecular biotechnology [Mol Biotechnol] 2024 Oct; Vol. 66 (10), pp. 2972-2984. Date of Electronic Publication: 2023 Oct 19.Publisher: Springer Country of Publication: Switzerland NLM ID: 9423533 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Pan‑cancer analysis of the oncogenic role of telomeric repeat binding factor 2 (TERF2) in human tumors and in vitro validation in gastric cancer by TERF2 knockdown

Authors : Qiang Ma; Wen Xu; Xiaolan Guo

Subjects: Telomeric repeat binding factor 2; TERF2; Bioinformatics analysis

Source: Discover Oncology, Vol 16, Iss 1, Pp 1-15 (2025)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Tissue factor targeted near-infrared photoimmunotherapy: a versatile therapeutic approach for malignancies

Authors : Seiichiro Takao; Hiroshi Fukushima; Aki Furusawa

Subjects: Tissue factor; Factor III; Near-infrared photoimmunotherapy

Source: Cancer Immunology, Immunotherapy, Vol 74, Iss 2, Pp 1-14 (2025)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Optimization of sustainable concrete incorporating coarse recycled aggregate using a customized single-factor response surface methodology (CSFRSM) approach

Authors : Said Almaawali; Majed A. A. Aldahdooh; Sultan A. M. Alnaamani

Subjects: Customized RSM; Single-factor optimization; Python-based correlation analysis

Source: Discover Civil Engineering, Vol 2, Iss 1, Pp 1-19 (2025)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Hypofractionated radiotherapy combined with a PD-1 inhibitor, granulocyte macrophage-colony stimulating factor, and thymosin-α1 in advanced metastatic solid tumors: a multicenter Phase II clinical trial

Authors : Jiamin Yu; Li Yin; Wenjie Guo

Subjects: Hypofractionated radiotherapy; Immunotherapy; PD-1 inhibitor

Source: Cancer Immunology, Immunotherapy, Vol 74, Iss 3, Pp 1-10 (2025)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Characterization of Cannabis usage in individuals with non-cancer chronic pain in the state of Maine using the Behavioral Risk Factor Surveillance System (BRFSS)

Authors : Rachel Bordonaro; Elizabeth N. Bean; Ling Cao

Subjects: Chronic pain; Maine; Cannabis

Source: Discover Public Health, Vol 22, Iss 1, Pp 1-17 (2025)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Exploring the Synergistic Mechanism of AP2A2 Transcription Factor Inhibition via Molecular Modeling and Simulations as a Novel Computational Approach for Combating Breast Cancer: In Silico Interpretations.

Authors : Niranjan V; Department of Biotechnology, RV College of Engineering, Bangalore, 560059, India. .; Setlur AS

Subjects: Transcription Factor AP-2*/Transcription Factor AP-2*/Transcription Factor AP-2*/metabolism ; Transcription Factor AP-2*/Transcription Factor AP-2*/Transcription Factor AP-2*/genetics ; Transcription Factor AP-2*/Transcription Factor AP-2*/Transcription Factor AP-2*/chemistry

Source: Molecular biotechnology [Mol Biotechnol] 2024 Sep; Vol. 66 (9), pp. 2497-2521. Date of Electronic Publication: 2023 Sep 25.Publisher: Springer Country of Publication: Switzerland NLM ID: 9423533 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Effect of RNAi-Mediated Survivin and Hypoxia-Inducible Factor 1α Gene Silencing on Proliferation, Invasion, Migration and Apoptosis of Gastric Cancer BGC-823 Cells.

Authors : Li Y; Basic Medical College, Beihua University, Jilin, Jilin, China.; Liu Y

Subjects: Survivin*/Survivin*/Survivin*/genetics ; Survivin*/Survivin*/Survivin*/metabolism ; Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/genetics

Source: Molecular biotechnology [Mol Biotechnol] 2024 Aug; Vol. 66 (8), pp. 1872-1882. Date of Electronic Publication: 2023 Jul 13.Publisher: Springer Country of Publication: Switzerland NLM ID: 9423533 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Asymmetric post-translational modifications regulate the nuclear translocation of STAT3 homodimers in response to leukemia inhibitory factor.

Authors : Diallo M; BioISI - Instituto de Biosistemas e Ciências Integrativas, Faculdade de Ciências da Universidade de Lisboa, Lisbon, 1749-016, Portugal.; MOSTMICRO Research Unit, Instituto de Tecnologia Química e Biológica (ITQB-NOVA), Universidade Nova de Lisboa, Oeiras, Portugal.

Subjects: Cell Nucleus*/Cell Nucleus*/Cell Nucleus*/metabolism ; Leukemia Inhibitory Factor*/Leukemia Inhibitory Factor*/Leukemia Inhibitory Factor*/metabolism ; Protein Multimerization*

Source: Cellular oncology (Dordrecht, Netherlands) [Cell Oncol (Dordr)] 2024 Jun; Vol. 47 (3), pp. 1065-1070. Date of Electronic Publication: 2023 Dec 27.Publisher: Springer Country of Publication: Netherlands NLM ID: 101552938 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

نتائج البحث

فلترة النتائج

The leukemia inhibitory factor regulates fibroblast growth factor receptor 4 transcription in gastric cancer.

Analysis of RNA Interference Targeted Against Human Antigen R (HuR) to Reduce Vascular Endothelial Growth Factor (VEGF) Protein Expression in Human Retinal Pigment Epithelial Cells.

Pan‑cancer analysis of the oncogenic role of telomeric repeat binding factor 2 (TERF2) in human tumors and in vitro validation in gastric cancer by TERF2 knockdown

Tissue factor targeted near-infrared photoimmunotherapy: a versatile therapeutic approach for malignancies

Optimization of sustainable concrete incorporating coarse recycled aggregate using a customized single-factor response surface methodology (CSFRSM) approach

Hypofractionated radiotherapy combined with a PD-1 inhibitor, granulocyte macrophage-colony stimulating factor, and thymosin-α1 in advanced metastatic solid tumors: a multicenter Phase II clinical trial

Characterization of Cannabis usage in individuals with non-cancer chronic pain in the state of Maine using the Behavioral Risk Factor Surveillance System (BRFSS)

Exploring the Synergistic Mechanism of AP2A2 Transcription Factor Inhibition via Molecular Modeling and Simulations as a Novel Computational Approach for Combating Breast Cancer: In Silico Interpretations.

Effect of RNAi-Mediated Survivin and Hypoxia-Inducible Factor 1α Gene Silencing on Proliferation, Invasion, Migration and Apoptosis of Gastric Cancer BGC-823 Cells.

Asymmetric post-translational modifications regulate the nuclear translocation of STAT3 homodimers in response to leukemia inhibitory factor.

اتصل بنا

اتبع